Monte Rosa Therapeutics
GLUE
GLUE
70 hedge funds and large institutions have $328M invested in Monte Rosa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 3 closing their positions.
Holders
70
Holders Change
+13
Holders Change %
+22.81%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
21
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$7.79M |
2 |
2
BlackRock
New York
|
$28.4M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$4.33M |
4 |
WP
4
Woodline Partners
San Francisco,
California
|
$4.11M |
5 |
5
Charles Schwab
San Francisco,
California
|
$1.74M |